Customers should stop using the alarm cable
Continue reading...28. February 2012
Comments Off
New adverse event and liver enzyme monitoring information in statin labels and updated drug interactions information in lovastatin label.
Continue reading...27. February 2012
Comments Off
UPDATED 02/27/2012. Product marketed as dietary supplement contain drug ingredient Tadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Continue reading...27. February 2012
Comments Off
Women may be left without adequate contraception, and at risk for unintended pregnancy.
Continue reading...24. February 2012
Comments Off
Doors and drawers may inadvertently open while bassinet is in motion; product may be difficult to maneuver due to it swivel caster configuration.
Continue reading...23. February 2012
Comments Off
UPDATED 04/04/2012 Cyanocobalamin Injection, USP, (1000 mcg/mL), 1mL Vial (Lot# 1662,1679 and 1683) recalled.
Continue reading...23. February 2012
Comments Off
Providers should not use the product lots listed for patient care and should immediately quarantine any product for return
Continue reading...23. February 2012
Comments Off
Difficulty disconnecting accessories from the tube may result may result in dislodgement of tube and could lead to serious patient injury or death
Continue reading...23. February 2012
Comments Off
Affects device and software that aids in the identification and mapping of areas of the brain.
Continue reading...22. February 2012
Comments Off
UPDATED 02/22/2012. Recall expanded to include all lots purchased on or before October 25, 2011. Recalled products pose significant risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Continue reading...
28. February 2012
Comments Off